Buying 1000 Shares Of SCHD: Here's The Dividends It Pays
1 extracted signal · 0 resolved · 1 still active
Peter PruIndependent analyst profile- Source published
- 15 Oct 2026, 19:00 UTC
- Recorded by Tahlil Plus
- 15 Oct 2026, 19:53 UTC

AI-generated source summary
The analysis focuses on the SCHD ETF, currently trading at $33.47 with a dividend yield of 3.2%. Over the past five years, SCHD has demonstrated an average dividend growth rate of 9.3% annually. The projected income from 1000 shares, which cost approximately $33,000, is estimated at over $1,000 per year initially, equating to roughly $0.27 per share quarterly or $88 per month. This represents an initial yield of approximately 3.2% on the investment. Over a 10-year period, with a 9.3% annual dividend growth, the income from these shares is projected to reach around $2,500 per year. By year 20, this income could potentially increase to $6,200 per year. The analysis further explores generating additional income through options strategies, specifically selling covered calls. With 1000 shares, one could hypothetically sell 10 covered call contracts. Estimating a premium of $25-$40 per contract per month, this could yield an additional $300 per month, or $3,600 per year, on top of the dividends. This combined income strategy, utilizing a quality dividend fund with a covered call overlay and a patient holding period, is presented as a means to generate substantial income regardless of market direction. The effective yield is presented as significantly higher with the options overlay compared to dividends alone. The video emphasizes the importance of disciplined strike selection and timing when implementing covered call strategies to avoid prematurely selling shares or missing potential upside.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
Peter Pru
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
